Knock-down of methyl CpG-binding protein 2 (MeCP2) causes alterations in cell proliferation and nuclear lamins expression in mammalian cells.
about
A Novel Role of Lamins from Genetic Disease to Cancer BiomarkersNuclear envelope structural proteins facilitate nuclear shape changes accompanying embryonic differentiation and fidelity of gene expressionDifferential Predictive Roles of A- and B-Type Nuclear Lamins in Prostate Cancer ProgressionMethyl-CpG binding protein 2 (MeCP2) localizes at the centrosome and is required for proper mitotic spindle organizationFunctional Profiling of Human MeCP2 by Automated Data Comparison Analysis and Computerized Expression Pathway ModelingMeCP2 Promotes Gastric Cancer Progression Through Regulating FOXF1/Wnt5a/β-Catenin and MYOD1/Caspase-3 Signaling Pathways.MicroRNA-4723 inhibits prostate cancer growth through inactivation of the Abelson family of nonreceptor protein tyrosine kinases.Glaucoma related Proteomic Alterations in Human Retina SamplesA Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In VitroNuclear atrophy of retinal ganglion cells precedes the bax-dependent stage of apoptosis.DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells.Functional assessment of MeCP2 in Rett syndrome and cancers of breast, colon, and prostate.MeCP2, a target of miR-638, facilitates gastric cancer cell proliferation through activation of the MEK1/2-ERK1/2 signaling pathway by upregulating GIT1.RNA sequencing and proteomics approaches reveal novel deficits in the cortex of Mecp2-deficient mice, a model for Rett syndrome.MeCP2 and CTCF: enhancing the cross-talk of silencers.Lack of Methyl-CpG Binding Protein 2 (MeCP2) Affects Cell Fate Refinement During Embryonic Cortical Development.
P2860
Q28072459-8B1B51F7-1A2D-42F3-909C-130C2A66151FQ28468582-C5452BF8-5213-4E3E-882D-BD0752E4F854Q28550287-E8D81014-9FAA-4D92-8C04-A2A5759F5D7DQ28910354-DB65D3E9-7A75-4F6C-947B-9BC37EACA68AQ31097619-663DBF10-C1BC-49C6-9EDF-64FE8C454E9CQ33809732-38222FDA-E53C-4C9A-B2F3-82D067A1E8B8Q35040740-45E2AA0F-411D-475C-B0E9-6746D1FBD93DQ36079578-69DAF5DC-A9AC-45E9-9112-8A9C20AFE9AAQ36394208-347EC693-666C-4256-B497-6A8BB470E76CQ36766582-DF0832DF-4B13-4D4F-9BAD-FF7F251FCFD6Q38743845-E4C23621-F751-47FC-8037-B201912AF16AQ39126183-92F6EF15-F43B-4AB2-A36C-475536BB08F5Q41228798-6ACBA287-D3D1-41C4-83BA-EDC3619BDE10Q43230803-28E3AAF9-47E4-4ADE-957D-EDA720610B85Q45303510-79429BD1-9211-4F73-8387-32B7B9DF999CQ47851474-193C7C6C-BBC4-4D84-8E46-F86839D60186
P2860
Knock-down of methyl CpG-binding protein 2 (MeCP2) causes alterations in cell proliferation and nuclear lamins expression in mammalian cells.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Knock-down of methyl CpG-bindi ...... expression in mammalian cells.
@ast
Knock-down of methyl CpG-bindi ...... expression in mammalian cells.
@en
Knock-down of methyl CpG-binding protein 2
@nl
type
label
Knock-down of methyl CpG-bindi ...... expression in mammalian cells.
@ast
Knock-down of methyl CpG-bindi ...... expression in mammalian cells.
@en
Knock-down of methyl CpG-binding protein 2
@nl
prefLabel
Knock-down of methyl CpG-bindi ...... expression in mammalian cells.
@ast
Knock-down of methyl CpG-bindi ...... expression in mammalian cells.
@en
Knock-down of methyl CpG-binding protein 2
@nl
P2093
P2860
P356
P1433
P1476
Knock-down of methyl CpG-bindi ...... expression in mammalian cells.
@en
P2093
Chiara Cassina
Christian Pistore
Elena Magnani
Elena Monti
Federica Babbio
Gianfranco Badaracco
Ian Marc Bonapace
Ilaria Castiglioni
Marzia Bruna Gariboldi
P2860
P2888
P356
10.1186/1471-2121-13-19
P577
2012-07-11T00:00:00Z
P5875
P6179
1038976221